Category - This Week’s Feature

This Week's Feature

MIRA advancing marijuana 2.0 for anxiety, cognitive decline, pain in seniors

MIRA Pharmaceuticals (NASDAQ:MIRA) is developing MIRA1a, a novel synthetic analog of THC (tetrahydrocannabinol) to treat anxiety and cognitive decline in the elderly and neuropathic pain, with a lower impurity profile...

September 19, 2023

This Week's Feature

Centessa focused on asset-centric, patient-centric drug development

Centessa Pharmaceuticals (NASDAQ:CNTA) is developing a portfolio of innovative drug candidates with small, focused R&D teams, a model it calls “asset-centric.”

June 20, 2023

Category - This Week’s Feature

MIRA advancing marijuana 2.0 for anxiety, cognitive decline, pain in seniors

Centessa focused on asset-centric, patient-centric drug development

General

More